Status:
COMPLETED
Cerebellar Transcranial Direct Current Stimulation in Parkinson's Disease
Lead Sponsor:
Thorsten Rudroff
Conditions:
Parkinson Disease
Brain Stimulation
Eligibility:
All Genders
50-90 years
Phase:
NA
Brief Summary
Parkinson's disease (PD) is the second most common neurodegenerative disorder and affects approximately 1 million people in the United States with total annual costs approaching 11 billion dollars. Th...
Detailed Description
Parkinson's disease (PD) is the second most common neurodegenerative disorder and affects approximately 1 million people in the United States with total annual costs approaching 11 billion dollars. Th...
Eligibility Criteria
Inclusion
- 1\) Adult (50-90 yrs) with a positive diagnosis of Parkinson's disease from a movement disorder specialist
- 2\) an unchanged regimen of dopaminergic medication for at least the last 3 months
- 3\) able to independently walk for 6 min
- 4\) without other chronic psychiatric or medical conditions
- 5\) not taking any psychoactive medications
Exclusion
- 1\) pregnant
- 2\) known holes or fissures in the skull
- 3\) metallic objects or implanted devices in the skull (e.g., metal plate, deep brain stimulator)
- 4\) current or previous injuries or surgeries that cause unusual gait
- 5\) score less than 24 or 17 on the Montreal Cognitive Assessment or telephone-Montreal Cognitive Assessment, respectively
- 6\) experience freezing of gait
- 7\) a diagnosis of dementia or other neurodegenerative diseases
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT04046055
Start Date
December 1 2019
End Date
April 1 2020
Last Update
November 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa
Iowa City, Iowa, United States, 52242